Susceptible Alleles of the CD40 and CTLA-4 Genes Are Not Associated with the Relapse after Antithyroid Withdrawal in Graves' Disease-Reference-Cited by-同舟云学术

Susceptible Alleles of the CD40 and CTLA-4 Genes Are Not Associated with the Relapse after Antithyroid Withdrawal in Graves' Disease

Published:2007-12 Issue:12 Volume:17 Page:1229-1234
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Kim Kyung Won¹,Park Young Joo¹²,Kim Tae Yong³,Park Do Joon¹,Park Kyong Soo¹,Cho Bo Youn¹

Affiliation:

1. Department of Internal Medicine, Seoul National University College of Medicine and Clinical Research Institute, Seoul National University Hospital, Seoul, Korea.

2. Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Gyeonggi, Korea.

3. Department of Internal Medicine, Asan Medical Center. University of Ulsan College of Medicine, Seoul, Korea.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2007.0011

Reference32 articles.

1. Differences and Similarities in the Diagnosis and Treatment of Graves' Disease in Europe, Japan, and The United States

2. International Differences in Approaches to 131I Therapy for Graves' Disease: Case Selection and Restrictions Recommended to Patients in Japan, Korea, and China

3. The incidence of recurrence and hypothyroidism following treatment with antithyroid drugs, surgery or radioiodine in all patients with thyrotoxicosis in Malmö during the period 1970-1974

4. A systematic review of drug therapy for Graves’ hyperthyroidism

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The genetics of Graves’ disease;Reviews in Endocrine and Metabolic Disorders;2023-12-18

2. Genotype-phenotype correlations in Graves’ disease;Best Practice & Research Clinical Endocrinology & Metabolism;2023-03

3. Research Progress on Influencing Factors of Graves’ Disease Recurrence Treated with Antithyroid Drugs;Advances in Clinical Medicine;2023

4. Association between the CTLA-4 EXON 1+49A/G Polymorphism and the Relapse of Grave’s Disease after ATD Withdrawal: A Meta-Analysis;Acta Endocrinologica (Bucharest);2022

5. Prediction of Relapse After Antithyroid Drugs Withdrawal: A Narrative Review;International Journal of Endocrinology and Metabolism;2020-06-29